← 返回前沿论文

分化型甲状腺癌与性别特异性免疫反应相关

英文原题:Differentiated Thyroid Cancer Is Associated With Sex-specific Immune Response.

查看英文原题

Differentiated Thyroid Cancer Is Associated With Sex-specific Immune Response.

PubMed 2025/11/07(内容时间) J Endocr Soc Q2 · IF 4.4(JCR 2025)

研究概要

我们的研究揭示了TC的TME中免疫细胞组成和基因表达存在显著的性别差异。男性表现出更强的免疫抑制特征,抑制性免疫标志物水平更高,功能性NK细胞频率更低。我们的发现强调了将性别特异性免疫特征纳入晚期TC靶向治疗开发的重要性。

研究思路结论见上方概要

甲状腺癌(TC)在发病率、进展和结局方面存在性别差异,育龄女性的预后比男性更有利。本研究探讨了TC中外周血和肿瘤微环境(TME)中免疫细胞动态的性别差异。

我们开展了一项前瞻性研究,纳入27例因TC或高风险甲状腺结节接受甲状腺切除术的患者(16例女性/11例男性)。收集组织和血液,采用流式细胞术和空间转录组学进行免疫细胞分析。使用DESeq2评估免疫相关基因的差异表达,并比较两性之间的免疫细胞频率。

男性在TME中显示出更高频率的增殖自然杀伤(NK)细胞(9.67 vs 1.29,P < .001)和T细胞免疫受体与Ig和ITIM结构域(Tigit)+ CD8 T细胞(2.34 vs 0.87,P = .04)。相比之下,女性倾向于具有更高频率的成熟NK(2.5 vs 1.08,P = .07)和CD8 T细胞(0.95 vs 0.68,P = .09)。空间转录组学显示,与女性相比,男性在周围正常组织和肿瘤边缘中HLA-DRB表达降低(P = .001,抗原呈递),并且在正常组织中LAG3有增加趋势(P = .09)。在肿瘤核心中,我们观察到男性相比女性IFNAR1(P = .04)、CD68(P = .04)和B2M(P = .02)增加。

展开英文摘要原文

BACKGROUND: Thyroid cancer (TC) exhibits sex-based disparities in incidence, progression, and outcomes, with women of reproductive age exhibiting more favorable prognoses than men. This study investigates sex differences in immune cell dynamics within peripheral blood and the tumor microenvironment (TME) in TC. METHODS: We performed a prospective study of 27 patients (16 females/11 males) undergoing thyroidectomy for TC or high-risk thyroid nodules. Tissue and blood were collected for immune cell analysis using flow cytometry and spatial transcriptomics. Differential-expression of immune-related genes was assessed with DESeq2, and immune cell frequencies were compared between sexes. RESULTS: Males showed higher frequencies of dividing natural killer (NK) cells (9.67 vs 1.29, P < .001) and T-cell immunoreceptor with Ig and ITIM domains (Tigit) + CD8 T cells (2.34 vs 0.87, P = .04) in the TME. In contrast, females tended to have higher frequencies of mature NK (2.5 vs 1.08, P = .07) and CD8 T-cells (0.95 vs 0.68, P = .09). Spatial transcriptomics revealed that men had reduced expression of HLA-DRB ( P = .001, antigen presentation) in both surrounding normal tissue and the tumor border and a trend for increased LAG3 ( P = .09) in normal tissue compared to women. In the core of the tumor, we observed increased IFNAR1 ( P = .04), CD68 ( P = .04), and B2M ( P = .02) in men vs women. CONCLUSION: Our study reveals significant sex-based differences in immune cell composition and gene expression within the TME of TC. Males exhibit a more immunosuppressive profile, with higher levels of inhibitory immune markers and lower frequencies of functional NK cells. Our findings highlight the importance of incorporating sex-specific immune profiles into development of targeted therapies for advanced TC.

论文信息

作者
Shobab L、Simpson J、McCoy M、Zheng H、Kumari S、Fan R、Budd S、Lee W
单位
Department of Medicine, Division of Endocrinology, MedStar Washington Hospital Center, Washington, DC 20010, USA.United States
期刊
Journal of the Endocrine Society2026 Jan
原文标识
PubMed 41357855 · DOI 10.1210/jendso/bvaf174